Microbix Biosystems Inc. (TSX:MBX)

Canada · Delayed Price · Currency is CAD

0.2200

-0.0050 (-2.22%)

At close: Feb 9, 2026

Revenue by Product

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
Antigens,Quality Assessment Products and DxTM	21.31M
Antigens,Quality Assessment Products and DxTM Growth	40.51%
Other (includes Kinlytic)	4.09M
Other (includes Kinlytic) Growth	202.60%

Revenue by Geography

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
North America	19.05M
North America Growth	75.84%
Europe	6.01M
Europe Growth	5.91%
Other Foreign Countries	332.61K
Other Foreign Countries Growth	8288.63%